Clinical trials
Recruiting Phase 1/2 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 16 |
| 2025 | 12 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 11 |
| AstraZeneca | 5 |
| BeOne Medicines | 5 |
| GlaxoSmithKline | 3 |
| Novartis Pharmaceuticals | 3 |
| Hoffmann-La Roche | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Regeneron Pharmaceuticals | 2 |
| Universidade do Sul de Santa Catarina | 2 |
| University of Sao Paulo | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 5 |
| Recurrence | 5 |
| Esophageal Neoplasms | 3 |
| Esophageal Squamous Cell Carcinoma | 3 |
| Lymphoma | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Multiple Myeloma | 3 |
| Neoplasms | 3 |
| Burkitt Lymphoma | 2 |
| Carcinoma, Hepatocellular | 2 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.